Health Elevar Therapeutics Announces Publication of Phase 3 CARES Globe News Wire Jul 25, 2023 FORT LEE, N.J., July 24, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for…
Health Elevar Therapeutics Submits New Drug Application to FDA for Globe News Wire May 17, 2023 FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar…